Tarsus Pharmaceuticals Set to Share Q3 2025 Results Soon

Author: Thomas Cooper Updated: 10-28-2025 05:03 PM

Tarsus Pharmaceuticals to Host Q3 2025 Financial Webcast

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is gearing up to report its third quarter financial results soon. On a live webcast scheduled for the afternoon, the company will provide insights into its financial performance and critical updates on its ongoing projects.

Details of the Upcoming Webcast

The live webcast will take place at 1:30 p.m. PT / 4:30 p.m. ET on November 4, 2025. This event will allow participants to tune in and engage with the latest developments at Tarsus. The webcast will also be recorded and accessible on the company's website for approximately 90 days, ensuring that anyone interested can catch up on what they missed.

Exploring Tarsus Pharmaceuticals' Impact on Eye Care

Tarsus Pharmaceuticals is committed to innovating treatment options and employing advanced scientific techniques. Their flagship product, XDEMVY (lotilaner ophthalmic solution) 0.25%, is FDA approved specifically for the treatment of Demodex blepharitis. This product highlights Tarsus's focus on addressing significant medical needs.

Pioneering New Treatments

In addition to XDEMVY, Tarsus is advancing its research on promising candidates like TP-04, an ophthalmic gel aimed at treating Ocular Rosacea, and TP-05, which is being evaluated as an oral tablet for preventing Lyme disease. Both of these developments are already in Phase 2 trials, representing Tarsus's commitment to tackling high unmet needs in various therapeutic areas.

Media and Investor Relations Contact Information

For those interested in media inquiries, Adrienne Kemp serves as the Senior Director of Corporate Communications. She can be reached at (949) 922-0801 or via email at AKemp@tarsusrx.com.

Investors Seeking Information

David Nakasone leads the Investor Relations team and is available for any investor-related questions at (949) 620-3223. You can contact him through email at DNakasone@tarsusrx.com.

Frequently Asked Questions

What will Tarsus Pharmaceuticals discuss in the webcast?

Tarsus will cover its third quarter financial results and provide a corporate update during the live event.

When is the Tarsus Pharmaceuticals webcast scheduled?

The webcast is set for November 4, 2025, at 1:30 p.m. PT / 4:30 p.m. ET.

How can I access the recorded version of the webcast?

After the live event, the recorded version will be available on the Tarsus website for about 90 days.

What products are currently advancing at Tarsus?

Tarsus is developing XDEMVY for Demodex blepharitis, TP-04 for Ocular Rosacea, and TP-05 for Lyme disease prevention.

Who can I contact for media or investor inquiries?

For media, reach out to Adrienne Kemp; for investment-related questions, contact David Nakasone via provided email or phone.

About The Author

Hello, I'm Thomas Cooper, a financial expert and writer passionate about helping people understand and navigate the financial world. Having a solid financial background and a lot of experience, my area of expertise is simplifying difficult financial ideas into useful, understandable guidance. My goal with my writings and blog entries is to provide you the information and resources you need to make wise financial choices.

I am thrilled to contribute my ideas and engage with a lively investor community at Investors Hangout, where I recently joined the team. My mission is to make finance interesting and approachable so you may take charge of your financial future. I appreciate you coming along on this path to success and financial knowledge.

Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.